Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125411302 | 12541130 | 2 | F | 201507 | 20160921 | 20160708 | 20160926 | EXP | US-ENDO PHARMACEUTICALS INC.-2016-001780 | ENDO | 80.51 | YR | F | Y | 71.73000 | KG | 20160926 | MD | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125411302 | 12541130 | 1 | PS | PREDNISONE TABLETS | PREDNISONE | 1 | Unknown | 40256 | 5 | MG | TABLETS | QD | |||||||
| 125411302 | 12541130 | 2 | SS | PREDNISONE TABLETS | PREDNISONE | 1 | 40256 | ||||||||||||
| 125411302 | 12541130 | 3 | SS | PREDNISONE TABLETS | PREDNISONE | 1 | 40256 | ||||||||||||
| 125411302 | 12541130 | 4 | SS | ELIQUIS | APIXABAN | 1 | Oral | 0 | 5 | MG | TABLETS | BID | |||||||
| 125411302 | 12541130 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Unknown | D | 0 | UNKNOWN | |||||||||
| 125411302 | 12541130 | 6 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | UNKNOWN | QD | |||||||||
| 125411302 | 12541130 | 7 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 50 | MG | TABLETS | QD | |||||||
| 125411302 | 12541130 | 8 | C | LECANIDE | 2 | Unknown | 0 | 50 | MG | TABLETS | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125411302 | 12541130 | 1 | Polymyalgia rheumatica |
| 125411302 | 12541130 | 2 | Pain |
| 125411302 | 12541130 | 3 | Immobile |
| 125411302 | 12541130 | 4 | Coagulopathy |
| 125411302 | 12541130 | 5 | Atrial fibrillation |
| 125411302 | 12541130 | 6 | Gastrooesophageal reflux disease |
| 125411302 | 12541130 | 7 | Coagulopathy |
| 125411302 | 12541130 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125411302 | 12541130 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125411302 | 12541130 | Alopecia | |
| 125411302 | 12541130 | Immobile | |
| 125411302 | 12541130 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125411302 | 12541130 | 1 | 201507 | 0 | ||
| 125411302 | 12541130 | 4 | 2014 | 0 | ||
| 125411302 | 12541130 | 5 | 201408 | 0 | ||
| 125411302 | 12541130 | 6 | 2011 | 0 |